Zeitschriftenaufsatz | 2012 Open Access

Comparative oncology: ErbB-1 and ErbB-2 homologues in canine cancer are susceptible to cetuximab and trastuzumab targeting.

Autor:in

Singer, Josef; Weichselbaumer, Marlene; Stockner, Thomas; Mechtcheriakova, Diana; Sobanov, Yury; Bajna, Erika; Wrba, Friedrich; Horvat, Reinhard; Thalhammer, Johann G; Willmann, Michael; Jensen-Jarolim, Erika;

Publikationen als Autor:in / Herausgeber:in der Vetmeduni

Willmann, Michael; Jensen-Jarolim, Erika

Journal

Molecular Immunology

Schlagwörter

Animals; Antibodies, Monoclonal/pharmacology; Antibodies, Monoclonal, Humanized/pharmacology; Antineoplastic Agents/pharmacology*; Breast Neoplasms/chemistry; Breast Neoplasms/genetics*; Breast Neoplasms/veterinary*; Cell Cycle/drug effects; Cell Separation; Cell Survival/drug effects; Dogs; Female; Flow Cytometry; Fluorescent Antibody Technique; Humans; Immunohistochemistry; Protein Structure, Quaternary; Receptor, Epidermal Growth Factor/chemistry; Receptor, Epidermal Growth Factor/genetics*; Receptor, erbB-2/chemistry; Receptor, erbB-2/genetics*; Sequence Homology, Amino Acid; Tumor Markers, Biological/analysis;

Dokumententyp

Originalarbeit

ISSN/eISSN

0161-5890 -

DOI

10.1016/j.molimm.2012.01.002

WoS ID

WOS:000302988400003

PubMed ID

22424313